Access 2.8M+ Filings Sign Up Free
Infant Bacterial Therapeutics Logo

Infant Bacterial Therapeutics | IBT - Profile, Filings, Stock Info & Investor Relations Data

Infant Bacterial Therapeutics | IBT
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Pharmaceuticals
Country
Sweden
Founded
2013
Infant Bacterial Therapeutics (IBT)

Company Profile

Website
Investor Relations

About Infant Bacterial Therapeutics

IBT is a pharmaceutical company with its registered office in Stockholm with a vision to develop drugs influencing the human infant microbiome, and thereby prevent or treat rare diseases affecting premature infants.

IBT is currently developing its lead drug candidate IBP-9414, to prevent NEC and improve feeding tolerance in premature infants. IBP-9414 contains the active compound Lactobacillus reuteri, which is a human bacterial strain naturally present in breast milk. IBT is further pursuing a second rare disease program IBP-1016 for the treatment of an unmet medical need in gastroschisis, a severe disease in infants. By developing these drugs, IBT has the potential to fulfill unmet needs for diseases where there are currently no prevention or treatment therapies available.

Headquarters

Bryggargatan 10
111 21, Stockholm
Sweden

Infant Bacterial Therapeutics (IBT)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Infant Bacterial Therapeutics (IBT)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

↑
Maria Ekdahl (Other)
Buy SEK 17,000.00 SEK 34.00 14.11.24
↑
Anthon Jahreskog (Other)
Buy SEK 79,033.80 SEK 94.20 08.02.24
↑
Anthon Jahreskog (Other)
Buy SEK 15,134.00 SEK 94.00 08.02.24
↑
Maria Ekdahl (Other)
Buy SEK 49,956.00 SEK 46.00 09.06.23
↑
Anders Kronström (Other)
Buy SEK 56,482.50 SEK 42.50 23.05.23
↑
Anthon Jahreskog (Other)
Buy SEK 36,593.00 SEK 43.00 23.05.23
↑
Maria Ekdahl (Other)
Buy SEK 19,995.00 SEK 43.00 23.05.23
↑
Anthon Jahreskog (Other)
Buy SEK 6,377.20 SEK 42.80 23.05.23
↑
Anthon Jahreskog (Other)
Buy SEK 6,269.92 SEK 42.08 23.05.23
↑
Maria Ekdahl (Other)
Buy SEK 30,487.00 SEK 43.00 22.05.23

Infant Bacterial Therapeutics (IBT)
Stock & Investor Information

ISINs

SE0008015242
SE0008015259
SE0020358190
SE0020358224

LEI

2138008KVBXCRJGP6Z26

Stock Exchange Listings

Nasdaq Stockholm

Industry Classification

Sector
Health Care
Industry
Pharmaceuticals